A recent study published in Scientific Reports (Nature) explores the potential of Hyperbaric Oxygen Therapy (HBOT) as a recovery tool for those suffering from Long COVID. As millions continue to struggle with “brain fog” and chronic fatigue, this prospective registry study provides new insights into how extra oxygen might help the body heal.
What the Research Found
The study followed patients undergoing HBOT and measured their progress at the three-month mark. The results showed a significant positive impact for many:
Clinically Relevant Improvement: Between 56% and 63% of long-term ill patients experienced a meaningful boost in their mental and physical health scores three months after treatment.
Cognitive Breakthroughs: The most notable improvements were found in the cognitive domain, offering hope for those battling concentration issues and mental clarity.
Symptom Reduction: Significant global declines in symptom burden were recorded, particularly for fatigue and concentration problems.
Why Oxygen Could Be the Key
Long COVID is believed to be caused by a mix of persistent inflammation, vascular damage, and mitochondrial dysfunction. HBOT addresses these underlying issues by:
Reducing Inflammation: Treatment has been shown to lower pro-inflammatory cytokines while increasing anti-inflammatory markers.
Boosting Repair Signaling: Through the “hyperoxic-hypoxic paradox,” repeated oxygen exposure can trigger the body’s natural repair pathways and stem cell mobilization.
Enhancing Brain Perfusion: Research indicates that HBOT can improve blood flow to brain regions responsible for memory and executive function.
Is it Safe?
The study notes that HBOT is generally well-tolerated and has a favourable harm profile. However, it is not a “one size fits all” solution:
Varying Responses: While the majority improved, approximately 13–19% of patients reported a deterioration in their condition after three months.
Need for Supervision: Researchers stress that patients should be monitored closely for any signs of worsening symptoms.
Dose Consistency: Shorter courses (such as only 10 sessions) may be insufficient; most structured recovery programs involve 20 to 40 sessions for durable results.
The Bottom Line
While Long COVID is not yet a standard approved indication for HBOT in many regions, this Nature registry adds to a growing body of evidence suggesting it can be a powerful adjunctive therapy. For those who haven’t responded to traditional symptomatic treatments, oxygen therapy may offer a path toward regaining daily function and quality of life.
